EZH2 and hepatocellular carcinoma: Studies have revealed that EZH2 elevates hepatocyte growth factor (HGF) and macrophage migration inhibitory factor (MIF) in hepatocellular carcinoma, which contribute to M2 repolarization and poor prognosis [22].